US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

ORUKA THERAPEUTICS INC

10.58

+1.2813.76%

Pre-market: 10.26-0.3200-3.02%04:11 EDT

Volume:217.20K

Turnover:2.18M

Market Cap:396.12M

PE:-2.50

High:10.61

Open:9.46

Low:9.12

Close:9.30

Loading ...

Overview Company News Filings

Company Profile

Company Name:

ORUKA THERAPEUTICS INC

Exchange:

NASDAQ

Establishment Date:

- -

Employees:

28

Office Location:

855 Oak Grove Avenue,Suite 100,Menlo Park,California,United States

Website:

http://orukatx.com

Zip Code:

94025

Phone:

Fax:

- -

Introduction:

ARCA biopharma, Inc., a clinical development stage biopharmaceutical company, engages in the development and commercialization of genetically targeted therapies for cardiovascular diseases. Its lead product candidate is Gencaro, a pharmacogenetically-targeted beta-adrenergic receptor antagonist that has completed Phase IIb trial for the treatment of atrial fibrillation in patients with chronic heart failure. It is also developing Recombinant Nematode Anticoagulant Protein c2 (rNAPc2) (AB201), a protein therapeutic that is in Phase IIb clinical trial for the treatment for COVID-19. ARCA biopharma, Inc. has a collaboration agreement with LabCorp to develop genetic test for GENETIC-AF clinical trial. The company was founded in 2004 and is headquartered in Westminster, Colorado.

Directors

Name

Position

Michael R. Bristow

President and Chief Executive Officer and Director

Robert E. Conway

Director, Chairman

Anders Hove

Director

Dan J. Mitchell

Director

Jacob Ma Weaver

Director

James Flynn

Director

Linda Grais

Director

Raymond L. Woosley

Director

Shareholders

Name

Position

Michael R. Bristow

President and Chief Executive Officer and Director

Thomas A. Keuer

Chief Operating Officer

C. Jeffrey Dekker

Chief Financial Officer

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/ORKA/company"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ORKA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ORKA\",,,,,undefined,":{"symbol":"ORKA","market":"US","secType":"STK","nameCN":"ORUKA THERAPEUTICS INC","latestPrice":10.58,"timestamp":1745352000000,"preClose":9.3,"halted":0,"volume":217195,"hourTrading":{"tag":"盘前","latestPrice":10.26,"preClose":10.58,"latestTime":"04:11 EDT","volume":1,"amount":10.26,"timestamp":1745395883126},"delay":0,"floatShares":24529621,"shares":37440510,"eps":-4.225857,"marketStatus":"Pre-Mkt","change":1.28,"latestTime":"04-23 05:11:10 EDT","open":9.46,"high":10.61,"low":9.12,"amount":2184702.170035,"amplitude":0.160215,"askPrice":16.57,"askSize":100,"bidPrice":7.32,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-4.225857,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1745415000000},"marketStatusCode":1,"adr":0,"listingDate":871012800000,"exchange":"NASDAQ","adjPreClose":10.58,"preHourTrading":{"tag":"盘前","latestPrice":10.26,"preClose":10.58,"latestTime":"04:11 EDT","volume":1,"amount":10.26,"timestamp":1745395883126},"postHourTrading":{"tag":"盘后","latestPrice":10.58,"preClose":10.58,"latestTime":"18:39 EDT","volume":167,"amount":1768.22,"timestamp":1745361572542},"volumeRatio":0.901123110277589,"impliedVol":0.3209,"impliedVolPercentile":0.1538},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ORKA\",,,,,undefined,":{"symbol":"ORKA","floatShares":24529621,"roa":"--","roe":"--","lyrEps":-3.873702,"volumeRatio":0.901123110277589,"shares":37440510,"dividePrice":0,"high":10.61,"amplitude":0.160215,"preClose":9.3,"low":9.12,"week52Low":5.485,"pbRate":"1.04","week52High":53.88,"institutionHeld":0.0223,"latestPrice":10.58,"eps":-4.225857,"divideRate":0,"volume":217195,"delay":0,"ttmEps":-4.225857,"open":9.46,"prevYearClose":19.39,"prevWeekClose":9.22,"prevMonthClose":10.26,"prevQuarterClose":10.26,"fiveDayClose":8.14,"twentyDayClose":12.36,"sixtyDayClose":12.19},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":1877171755,"employeeNum":28,"address":"855 Oak Grove Avenue,Suite 100,Menlo Park,California,United States","zipCode":"94025","officePhone":"(650) 606-7910"},"stockCompanyDetail":{"websiteUrl":"http://orukatx.com","stockEarnings":[{"period":"1week","weight":0.236},{"period":"1month","weight":-0.1256},{"period":"3month","weight":-0.1536},{"period":"6month","weight":-0.6438},{"period":"1year","weight":-0.7444},{"period":"ytd","weight":-0.4544}],"compareEarnings":[{"period":"1week","weight":-0.0193},{"period":"1month","weight":-0.0651},{"period":"3month","weight":-0.1306},{"period":"6month","weight":-0.0898},{"period":"1year","weight":0.0551},{"period":"ytd","weight":-0.1004}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"ARCA biopharma, Inc., a clinical development stage biopharmaceutical company, engages in the development and commercialization of genetically targeted therapies for cardiovascular diseases. Its lead product candidate is Gencaro, a pharmacogenetically-targeted beta-adrenergic receptor antagonist that has completed Phase IIb trial for the treatment of atrial fibrillation in patients with chronic heart failure. It is also developing Recombinant Nematode Anticoagulant Protein c2 (rNAPc2) (AB201), a protein therapeutic that is in Phase IIb clinical trial for the treatment for COVID-19. ARCA biopharma, Inc. has a collaboration agreement with LabCorp to develop genetic test for GENETIC-AF clinical trial. The company was founded in 2004 and is headquartered in Westminster, Colorado.","yearOnYearQuotes":[{"month":1,"riseRate":0.3125,"avgChangeRate":0.038367},{"month":2,"riseRate":0.352941,"avgChangeRate":-0.074511},{"month":3,"riseRate":0.352941,"avgChangeRate":-0.027833},{"month":4,"riseRate":0.588235,"avgChangeRate":0.097075},{"month":5,"riseRate":0.5,"avgChangeRate":0.09678},{"month":6,"riseRate":0.25,"avgChangeRate":0.477078},{"month":7,"riseRate":0.5,"avgChangeRate":0.014024},{"month":8,"riseRate":0.0625,"avgChangeRate":-0.146138},{"month":9,"riseRate":0.3125,"avgChangeRate":-0.080322},{"month":10,"riseRate":0.4375,"avgChangeRate":-0.053682},{"month":11,"riseRate":0.625,"avgChangeRate":0.003334},{"month":12,"riseRate":0.5,"avgChangeRate":-0.003439}],"exchange":"NASDAQ","name":"ORUKA THERAPEUTICS INC","nameEN":"ORUKA THERAPEUTICS INC"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"ORKA\",market:\"US\",,,undefined,":{"directors":[{"name":"Michael R. Bristow","position":"President and Chief Executive Officer and Director"},{"name":"Robert E. Conway","position":"Director, Chairman"},{"name":"Anders Hove","position":"Director"},{"name":"Dan J. Mitchell","position":"Director"},{"name":"Jacob Ma Weaver","position":"Director"},{"name":"James Flynn","position":"Director"},{"name":"Linda Grais","position":"Director"},{"name":"Raymond L. Woosley","position":"Director"}],"executives":[{"name":"Michael R. Bristow","position":"President and Chief Executive Officer and Director"},{"name":"Thomas A. Keuer","position":"Chief Operating Officer"},{"name":"C. Jeffrey Dekker","position":"Chief Financial Officer"}]},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ORKA\",params:#limit:5,,,undefined,":[{"market":"US","date":"2024-09-03","symbol":"ORKA","defaultRemindTime":1725370200000,"type":"split","dateTimestamp":1725336000000,"forFactor":12,"toFactor":1,"ratio":12},{"date":"2024-08-29","symbol":"ORKA","amount":1.613,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-08-26","defaultRemindTime":1724938200000,"name":"方舟生物医药","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-08-28","payableDate":"2024-08-26","currency":"USD","dateTimestamp":1724904000000,"payDate":"2024-08-28"},{"market":"US","date":"2024-08-01","symbol":"ORKA","fiscalQuarterEnding":"2024/06","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1722484800000,"reportTimeType":"post","actualEps":-0.18},{"market":"US","date":"2024-04-25","symbol":"ORKA","fiscalQuarterEnding":"2024/03","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1714017600000,"reportTimeType":"post","actualEps":-0.14},{"market":"US","date":"2024-02-01","symbol":"ORKA","fiscalQuarterEnding":"2023/12","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1706763600000,"reportTimeType":"post","actualEps":-0.08}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ORKA\",market:\"US\",,,undefined,":[{"executeDate":"2024-08-29","recordDate":"2024-08-26","paymentDate":"2024-08-28","value":1.613,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ORKA\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.625,"buy":0.375,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.625,"analysts":8,"updateTime":1738641600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ORKA\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ORKA","date":"2025-04-21","current":-3.779499,"percent":0.655172,"low":-5.124049,"twenty":-4.878914,"median":-4.198946,"eighty":-3.311366,"high":-2.779284,"avg":-4.115831,"sd":0.729732,"marketCap":345201502},"quantilePoints":[{"date":"2025-03-14","current":-4.566552,"twenty":-4.600166,"median":-4.533759,"eighty":-4.155287,"marketCap":417087281},{"date":"2025-03-21","current":-4.898591,"twenty":-4.788731,"median":-4.634189,"eighty":-4.465422,"marketCap":447414094},{"date":"2025-03-28","current":-4.898591,"twenty":-4.90187,"median":-4.734621,"eighty":-4.543597,"marketCap":447414094},{"date":"2025-04-04","current":-3.656521,"twenty":-4.90187,"median":-4.68543,"eighty":-4.155287,"marketCap":333969349},{"date":"2025-04-11","current":-3.021139,"twenty":-4.898591,"median":-4.546056,"eighty":-3.567158,"marketCap":275936558},{"date":"2025-04-17","current":-3.529445,"twenty":-4.883833,"median":-4.205819,"eighty":-3.28595,"marketCap":322362791},{"date":"2025-04-21","current":-3.779499,"twenty":-4.878914,"median":-4.198946,"eighty":-3.311366,"marketCap":345201502}],"updateTime":1745380195991}}}